Key Takeaways
- • TD Cowen raised its price target on Ares Management (ARES) to $197.00, representing a 12.57% increase from the prior target, while maintaining a Buy rating on the shares.
- • Analyst consensus on ARES spans a wide range, with a median twelve-month price target of $180.00, a high estimate of $222.00, and a low estimate of $112.00, indicating significant dispersion in market views.
- • Recent analyst activity shows mixed signals: while TD Cowen upgraded its target, other firms including Morgan Stanley (lowered to $163 from $178) and Barclays (adjusted to $127) have reduced their price targets, reflecting divergent views on the alternative asset manager's near-term prospects.
- • The consensus average price target across 18 analysts stands at $167.73, suggesting the market is pricing in modest upside from current trading levels.
Summary
Ares Management faces conflicting analyst sentiment as of April 2026, with TD Cowen's recent price target increase to $197.00 offsetting broader downward revisions from competing research teams. The 12.57% raise from TD Cowen's prior target represents the firm's conviction in Ares' strategic positioning, though the action stands in contrast to contemporaneous downgrades from Morgan Stanley and Barclays, which lowered their respective targets to $163 and $127.
The disparity in analyst projections reflects uncertainty around the alternative asset manager's medium-term trajectory. The median price target of $180.00 across the research community, paired with a high estimate of $222.00 and a low of $112.00, underscores the significant range of outcomes analysts are modeling. This $110 spread between high and low estimates suggests material disagreement on valuation drivers, business momentum, or macroeconomic headwinds affecting the alternative investment sector.
Aggregate consensus places the eighteen-analyst average price target at $167.73, implying limited upside from levels at which ARES was trading during this period. The presence of Zacks research assigning a "strong sell" rating and noting that the stock trades below consensus targets suggests that investor sentiment has grown cautious despite select analysts maintaining constructive stances. For institutional investors evaluating the opportunity, the variance in professional opinion warrants careful attention to the specific assumptions underlying each analyst's model—particularly regarding fee compression, asset growth, and capital deployment returns in Ares' diverse platform spanning credit, private equity, and infrastructure.
The disparity in analyst projections reflects uncertainty around the alternative asset manager's medium-term trajectory. The median price target of $180.00 across the research community, paired with a high estimate of $222.00 and a low of $112.00, underscores the significant range of outcomes analysts are modeling. This $110 spread between high and low estimates suggests material disagreement on valuation drivers, business momentum, or macroeconomic headwinds affecting the alternative investment sector.
Aggregate consensus places the eighteen-analyst average price target at $167.73, implying limited upside from levels at which ARES was trading during this period. The presence of Zacks research assigning a "strong sell" rating and noting that the stock trades below consensus targets suggests that investor sentiment has grown cautious despite select analysts maintaining constructive stances. For institutional investors evaluating the opportunity, the variance in professional opinion warrants careful attention to the specific assumptions underlying each analyst's model—particularly regarding fee compression, asset growth, and capital deployment returns in Ares' diverse platform spanning credit, private equity, and infrastructure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.